|Bid||0.0000 x 900|
|Ask||0.0000 x 1100|
|Day's Range||1.6500 - 1.7500|
|52 Week Range||0.3500 - 8.1800|
|Beta (5Y Monthly)||2.71|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
ASLAN Pharmaceuticals (ASLN) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
ASLAN Pharmaceuticals Ltd. (ASLN) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SINGAPORE, July 13, 2020 -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative.